One last time at #EASL2025: Wim Laleman (KUL) hosts the EASL/CIRSE Skills Learning Centre session on #Liver #Haemodynamics, providing hands-on learning in liver disease management. 🕙 10:15 – 11:15, Skills Learning Centre 2 @easlnews.bsky.social @cirsesociety.bsky.social

👏 What an accomplishment 🥳 Frederike Krus selected for this afternoon's #PosterTour at #EASLCongress 👉 POSTER ID FRI-175 Loss of hepatic #leptin clearance is associated with the development of #ACLF, acute-on-chronic #LiverFailure 📍 #Cirrhosis & Complications 📅 Fri, 9 May @medblab.bsky.social

Great talk by Frederike Krus on the hepatic Leptin clearance in #ACLF at the poster tour. #EASLCongress #EASL2025

🔬 Maximilian Brol's #POSTER FRI-493 👉 Conversion from standard-release to prolonged-release tacrolimus mitigates #calcineurin-induced #nephrotoxicity in patients after #LiverTransplantation The poster is still up until 17:00 today ☺️ 📅 Presented at #EASLCongress 2025 @medblab.bsky.social

🌟 Rising star - first big conference for him, so give him an applause 👏! Hendrik Rogge presents a great #poster today at #EASLCongress about the 📊 prediction of circulatory failure in intensive-care #patients with liver #cirrhosis & #ACLF. 👉 #POSTER FRI-182, up until 17h @medblab.bsky.social

🩺 #POSTER FRI-226 by Wenyi Gu (@medblab.bsky.social at the Universitätsklinikum Münster #UKM) presents her newest results on the burden & impact of #extrahepatic organ failures in European patients with #cirrhosis. 📅 Presented at #EASLCongress | #EASL2025, up until 17h, still time to swing by ☺️

Prof. JonelTrebicka presents and discusses the development and success of #TIPS over the past 25 years, high above the rooftops of #Amsterdam.

🔬👩‍🔬 Big news: Loss of hepatic #leptin clearance is associated with the development of acute-on-chronic liver failure #ACLF #POSTER FRI-175 by Frederike Krus (Universität Münster, @medblab.bsky.social) - don’t miss it, up until 17h today! 📅 Presented at #EASLCongress 2025 #LiverFailure #cirrhosis

Hendrik Rogge presents his poster on circulatory failure prediction in #ACLF patients. #EASLCongress #EASL2025

Is Leptin involved in progression of #ChronicLiverDisease to #ACLF? Find it out at poster FRI-175 from Frederike Krus. #EASLCongress #EASL2025

Come and visit Max Brol's poster FRI-493 at lunchtime today. #EASLCongress #EASL2025

Don’t miss this #poster: 🔬 Sex-specific #estradiol signalling in liver #cirrhosis: THU-149-YI Fabian Schachteli (@medblab.bsky.social) investigated the role of sex-specific estradiol signalling in the pathophysiology of liver cirrhosis and portal hypertension. #EASLCongress #EASL2025

🐭 Blockage of microfibrillar-associated protein 4 (MFAP4) decreases liver fibrosis in two murine models of steatotic liver disease #POSTER THU-058-YI by Maximilian Brol (UM) presents preclinical data showing that blocking MFAP4 reduces #liver #fibrosis in two murine models. #EASL2025

No time to visit the Skills Learning Centre yesterday? 🫣 No problem - join Wim Laleman today at 10h, 14h or 16:15h for is in-depth session on #Liver #Haemodynamics! 💡 #Today at #EASLCongress #EASL2025 @easlnews.bsky.social @cirsesociety.bsky.social

Lively discussions at Max Brol's poster on the beneficial role of MFAP4 inhibition in steatotic #LiverDisease at #EASLCongress. #EASL2025

Come and see Kai Peiffer's poster THU-170 on HBV-specific metabolic footprints and impact on mortality in patients with #HBV reactivation and #ACLF at #EASLCongress.

At poster THU-149-YI Fabian Schachteli is happy to guide you through his work on sex-specific estradiol signaling in biliary cirrhosis. #EASLCongress

🔬 Live from #EASLCongress 👉 Jonel Trebicka @medblab.bsky.social presents as panelist in the session “From Covered #TIPS to TIPS using Controlled Expansion" in Ring-Larsen Room. 💡 An insightful discussion on the latest advancements in TIPS technology for managing #cirrhosis complications 👏

🔬 EASL/CIRSE Skills Learning Centre: Liver Haemodynamics Join Wim Laleman (KUL) for an in-depth session on Liver Haemodynamics 📅 Presented at the #EASLCongress | #EASL2025 🕙 10:00 – 11:00 Also available at 12:30, 14:00, and 16:15! @easlnews.bsky.social @cirsesociety.bsky.social

Prof Jonel Trebicka speaks about the evolution of #TIPS at #EASLCongress. #GoreMedical

For the coming days you will find many of our LiSyM members at the #EASLCongress in Amsterdam. We wish you all a great time to exchange ideas💡

We’re kicking off the MICROB-PREDICT Networking Session at #EASL2025! Prof. Dr. Jonel Trebicka @medblab.bsky.social starts with an overview: our mission to identify microbiome-based biomarkers and mechanisms that can predict, where the body can no longer compensate for liver dysfunction.

We were diving even deeper into today’s #MICROBPREDICT Networking Session at #EASL2025! 🦠🧬💉 From virome insights to gut-barrier mechanisms and the ALB-Trial - Brol, Tornai & Torp present key MICROB-PREDICT findings driving innovation in cirrhosis research. @medblab.bsky.social

Sun is out for MICROB-PREDICT's ALB Trial Meeting #EASL2025! 🌞 Jonel Trebicka & Nikolaj Torp are joined by investigators and consortium partners to evaluate progress and coordinate next steps for our interventional study targeting acute decompensation in cirrhosis. @medblab.bsky.social

🩺 TIPS for portal hypertensive gastropathy (PHD) bleeding reduces further #decompensation & mortality #POSTER WED-258 by Zeyu Wang presented clinical findings on the use of #TIPS to manage PHG bleeding, showing reduced rates of further decompensation & mortality. #EASL2025 @medblab.bsky.social

🤝 We’re live at the EF CLIF Networking Session at #EASL2025! Partners and collaborators are gathering to exchange insights on cirrhosis and its complications, building bridges between research and clinical innovation. 📍 Cirrhosis & Complications Track Hub @easlnews.bsky.social

More on #PortalHypertension: 💡 TIPS for hydropic decompensation improves short-term outcome: a case-control study #poster WED-186 by Eduardo Cervantes-Alvarez (@medblab.bsky.social), presented clinical data on the role of #TIPS in managing hydropic #decompensation of liver #cirrhosis. #EASL2025

2️⃣ The 📊 prognostic performance of MELD 3.0 was also evaluated in patients undergoing transjugular intrahepatic portosystemic #shunt placement #TIPS (a retrospective multicentre study) by Markus Kimmann (WED-229-YI) 📅 Presented at #EASLCongress | #EASL2025 #LiverDisease #ClinicalTrials #Hepatology

At poster WED-503 Dominik Lüttgen presents a clinical decision tree for non-invasive diagnosis of #steatosis at #EASLCongress.

Viktoria Iwan presents her study on gene editing for #Wilsondisease at poster WED-351 at #EASLCongress.

Max Brol presents the @microb-predict.bsky.social Predict Virome data at Track Hub 4. #EASLcongress

The @microb-predict.bsky.social session at Track Hub 4 is presented by #JonelTrebicka at #EASLCongress.

The poster WED-194-YI on treatment response to terlipressin in acute #kidney injury is presented by @frankuschner.bsky.social at #EASLCongress.

Eduardo Cervantes presents his case-control study on TIPS in hydropic decompensation at poster WED-186 #EASLCongress.

Visit Josune Cabello at her poster WED-118-YI on shift of #liver disease etiologies in #Germany at #EASLCongress.

Zeyu Wang is happy to discuss with you on his poster WED-258 at #EASLCongress.

Markus Kimmann presents his poster about the prognostic performance of the #MELD 3.0 at the #EASLCongress. He will be at his poster around lunchtime to answer your questions.

We are ready for #EASLCongress. We are happy to welcome you at our Posters.

📣 Meet the MICROB-PREDICT team during our Networking Session at #EASLCongress to learn more about the virome's role in #cirrhosis, how villin-1 + IgA influence #GutBarrier function, and about the ALB-trial ⚕️ 📅 Wednesday 7 May, 14:00-14:30 📍 Cirrhosis & Complications Track Hub @easlnews.bsky.social

🧪 Treatment response to Terlipressin in patients with acute kidney injury hepatorenal syndrome and preexisting chronic kidney disease – the German liver cirrhosis / CKD-Terli study group #POSTER WED-194-YI by Frank Erhard Uschner @frankuschner.bsky.social (UM) #EASL2025

📣 Swing by at our Networking Session here at #EASLCongress in Amsterdam tomorrow - beginning with an introduction by project coordinator Jonel Trebicka, followed by talks on the role of the #virome in #cirrhosis, how #villin-1 + #IgA impact the #GutBarrier function, and of course about the #ALBTrial

🧬 Correction of the Wilson disease H1069Q point mutation by CRISPR/Cas9-mediated gene editing in induced pluripotent stem cells #POSTER WED-351 by Viktoria Iwan @medblab.bsky.social gives a gene-editing approach via #CRISPR/Cas9 to correct H1069Q point mutation in iPSCs for Wilson disease #EASL2025

🩺 Clinical decision tree for non-invasive diagnosis of graft steatosis in liver transplant patients #POSTER WED-503 by Dominik Lüttgen @medblab.bsky.social presents a structured approach to support the non-invasive diagnosis of graft steatosis in liver transplant recipients. #EASL2025

🩺 Shifting etiologies and emerging metabolic factors of hepatocellular #carcinoma from 2005 to 2020: a German nationwide population-based study Check out #POSTER WED-118-YI by Josune Cabello Calleja, exploring 15 years of nationwide data on evolving HCC #RiskFactors. #EASL2025 @medblab.bsky.social

📣🚨The ECLCB-9 is online🚨📣 Join the 9th European Club for Liver Cell Biology in September in #Groningen (NL) co-organised by @medblab.bsky.social director Prof. Jonel Trebicka. ❗📃 Abstract submission deadline: 30 May 2025 ❗✏️ Registration deadline: 30 June 2025 #ECLCB9 www.eclcb9.com/home

ICYMI: New online! A Consensus Statement on establishing causality, therapeutic applications and the use of preclinical models in microbiome research

The team of Jonel Trebicka and colleagues have published the CLIF-SIG score that allows accurate estimation of systemic #inflammation and prognosis in patients with acutely decompensated #cirrhosis. @uni-muenster.de gut.bmj.com/content/earl...

In a global effort involving Prof. Trebicka, a consensus document was compiled with the aim of harmonizing the #ACLF definitions from Asia, North America and Europe. This document recognizes the regional variations and paves the way for a global ACLF definition. link.springer.com/article/10.1...

Most viewed in the last 7 days from JAMA: The addition of simvastatin plus rifaximin to standard therapy does not improve outcomes in patients with decompensated liver cirrhosis. https://ja.ma/4hYuPAm

🚀 7th GA #Meeting in Cologne, Germany from 27-29 January 2025! A huge thank you to everyone for sharing their latest results and project updates! 👏 And of course, we wrapped it up with some after-work fun, exploring Cologne with a @sciencerallye.bsky.social! 🏙️ ⛲